-Reuters
Organon Inks Licensing Pact For Daré Bioscience’s Bacterial Vaginosis Treatment
Organon & Co (NYSE: OGN)
Related Posts
Biden Delivers Remarks On Plans To Combat Coronavirus (Link)
https://www.youtube.com/watch?v=FFxPz0QVgw4
JMP Securities Maintains Market Outperform on Perella Weinberg Partners, Raises Price Target to $18
JMP Securities analyst Devin Ryan maintains Perella Weinberg Partners (NASDAQ:PWP) with a Market Outperform and raises the price target from $17 to $18.
UPDATE: Assertio Therapeutics Q3 Adj. EPS $0.22 Beats $0.07 Estimate
Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 175 percent increase over earnings of $0.08 per share